Blastocyst-endometrium interaction: Intertwining a cytokine network

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 11, 2006, Pages 1373-1385

  Castro Rendón, Wilson A ^a   Castro Alvarez J F ^a   Guzman Martinez C ^a   Bueno Sanchez, J C ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Aspirin; Cytokines; Embryo implantation; Prostaglandins; Trophoblast

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; EMFILERMIN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1; LEUKEMIA INHIBITORY FACTOR; PROSTAGLANDIN E2; STEROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

BLASTOCYST; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); DRUG TARGETING; EMBRYO DEVELOPMENT; ENDOMETRIUM; ENZYME INHIBITION; FERTILIZATION; GENE INTERACTION; GENE TARGETING; GENITAL SYSTEM; HUMAN; LUNG CANCER; MITOSIS; NIDATION; NONHUMAN; PREIMPLANTATION EMBRYO; PROTEIN FUNCTION; REVIEW; STROMA CELL; TOTIPOTENT STEM CELL; TROPHOBLAST;

MAMMALIA;

EID: 33847624201     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006001100001     Document Type: Review

References (60)

1. Kaye PL. Preimplantation growth factor physiology. Rev Reprod 1997; 2: 121-127.
2. Kimber SJ. Cell biology of implantation and plancentation. Introduction. Semin Cell Dev Biol 2000; 11: 61-65.
3. Shaw TJ, Murphy CR. Leucocyte involvement in lectin-induced deciduomata formation. Cell Biol Int 1995; 19: 577-584.
4. Pollheimer J, Knofler M. Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. Placenta 2005; 26 (Suppl A): S21-S30.
5. Cooke S, Quinn P, Kime L, Ayres C, Tyler JP, Driscoll GL. Improvement in early human embryo development using new formulation sequential stage-specific culture media. Fertil Steril 2002; 78: 1254-1260.
6. Watson AJ. The cell biology of blastocyst development. Mol Reprod Dev 1992; 33: 492-504.
7. Krussel JS, Simon C, Rubio MC, Pape AR, Wen Y, Huang HY, et al. Expression of interleukin-1 system mRNA in single blastomeres from human preimplantation embryos. Hum Reprod 1998; 13: 2206-2211.
8. Paula-Lopes FF, de Moraes AA, Edwards JL, Justice JE, Hansen PJ. Regulation of preimplantation development of bovine embryos by interleukin-1beta. Biol Reprod 1998; 59: 1406-1412.
9. Sheth KV, Roca GL, al-Sedairy ST, Parhar RS, Hamilton CJ, al-Abdul JF. Prediction of successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive factor(s) in preimplantation embryo culture fluid. Fertil Steril 1991; 55: 952-957.
10. Kruessel JS, Huang HY, Wen Y, Kloodt AR, Bielfeld P, Polan ML. Different pattern of interleukin-1 beta- (IL-1 beta), interleukin-1 receptor antagonist- (IL-1ra) and interleukin-1 receptor type I- (IL-1R tl) mRNA-expression in single preimplantation mouse embryos at various developmental stages. J Reproof Immunol 1997; 34: 103-120.
11. Lazzaroni L, Fusi FM, Doldi N, Ferrari A. The use of Matrigel at low concentration enhances in vitro blastocyst formation and hatching in a mouse embryo model. Fertil Steril 1999; 71: 1133-1137.
12. Ouhibi N, Hamidi J, Guillaud J, Menezo Y. Co-culture of 1-cell mouse embryos on different cell supports. Hum Reprod 1990; 5: 737-743.
13. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med 2001; 345: 1400-1408.
14. Senturk LM, Arici A. Leukemia inhibitory factor in human reproduction. Am J Reprod Immunol 1998; 39: 144-151.
15. Tsai HD, Chang CC, Hsieh YY, Lo HY, Hsu LW, Chang SC. Recombinant human leukemia inhibitory factor enhances the development of preimplantation mouse embryo in vitro. Fertil Steril 1999; 71: 722-725.
16. Lavranos TC, Rathjen PD, Seamark RF. Trophic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos. J Reprod Fertil 1995; 105: 331-338.
17. Chabbert-Buffet N, Bouchard P. The normal human menstrual cycle. Rev Endocr Metab Disord 2002; 3: 173-183.
18. Rider V. Progesterone and the control of uterine cell proliferation and differentiation. Front Biosci 2002; 7: d1545-d1555.
19. Okada S, Okada H, Sanezumi M, Nakajima T, Yasuda K, Kanzaki H. Expression of interleukin-15 in human endometrium and decidua. Mol Hum Reprod 2000; 6: 75-80.
20. Dimitriadis E, Salamonsen LA, Robb L. Expression of interleukin-11 during the human menstrual cycle: coincidence with stromal cell decidualization and relationship to leukaemia inhibitory factor and prolactin. Mol Hum Reprod 2000; 6: 907-914.
21. King A. Uterine leukocytes and decidualization. Hum Reprod Update 2000; 6: 28-36.
22. Fazleabas AT, Strakova Z. Endometrial function: cell specific changes in the uterine environment. Mol Cell Endocrinol 2002; 186: 143-147.
23. McMaster MIT Newton RC, Dey SK, Andrews GK. Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol 1992; 148: 1699-1705.
24. von Wolff M, Classen-Linke I, Heid D, Krusche CA, Beier-Hellwig K, Karl C, et al. Tumour necrosis factor-alpha (TNF-alpha) in human endometrium and uterine secretion: an evaluation by immunohisto-chemistry, ELISA and semiquantitative RT-PCR. Mol Hum Reprod 1999; 5: 146-152.
25. Milne SA, Perchick GB, Boddy SC, Jabbour HN. Expression, localization, and signaling of PGE(2) and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle. J Clin Endocrinol Metab 2001; 86: 4453-4459.
26. Huang JC, Liu DY, Yadollahi S, Wu KK, Dawood MY. Interleukin-1 beta induces cyclooxygenase-2 gene expression in cultured endometrial stromal cells. J Clin Endocrinol Metab 1998; 83: 538-541.
27. Majerus PW. Prostaglandins: critical roles in pregnancy and colon cancer. Curr Biol 1998; 8: R87-R89.
28. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, et al. Multiple female reproductive failures in cyclooxygnenase 2-deficient mice. Cell 1997; 91: 197-208.
29. Reese J, Zhao X, Ma WG, Brown N, Maziasz TJ, Dey SK. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice. Endocrinology 2001; 142: 3198-3206.
30. Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction 2005; 130: 131-145.
31. Ni H, Sun T, Ding NZ, Ma XH, Yang ZM. Differential expression of microsomal prostaglandin E synthase at implantation sites and in decidual cells of mouse uterus. Biol Reprod 2002; 67: 351-358.
32. Ni H, Sun T, Ma XH, Yang ZM. Expression and regulation of cytosolic prostaglandin E synthase in mouse uterus during the peri-implantation period. Biol Reprod 2003; 68: 744-750.
33. Jabbour HN, Boddy SC. Prostaglandin E2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway. J Clin Endocrinol Metab 2003; 88: 4481-4487.
34. Pollack SB, Linnemeyer PA. Natural killer cells in the nonpregnant murine uterus. Nat Immun 1996; 15: 34-40.
35. Linnemeyer PA, Pollack SB. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells. J Immunol 1993; 150: 3747-3754.
36. Leach RE, Khalifa R, Ramirez ND, Das SK, Wang J, Dey SK, et al. Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab 1999; 84: 3355-3363.
37. Moller B, Rasmussen C, Lindblom B, Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 2001; 7: 65-72.
38. Cavagna M, Mantese JC. Biomarkers of endometrial receptivity - a review. Placenta 2003; 24 (Suppl B): S39-S47.
39. Das SK, Wang XN, Paria BC, Damm D, Abraham JA, Klagsbrun M, et al. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 1994; 120: 1071-1083.
40. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76-79.
41. Chen JR, Cheng JG, Shatzer T, Sewell L, Hernandez L, Stewart CL. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 2000; 141: 4365-4372.
42. Vogiagis D, Fry RC, Sandeman RM, Salamonsen LA. Leukaemia inhibitory factor in endometrium during the oestrous cycle, early pregnancy and in ovariectomized steroid-treated ewes. J Reprod Fertil 1997; 109: 279-288.
43. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995; 80: 1908-1915.
44. Ni H, Ding NZ, Harper MJ, Yang ZM. Expression of leukemia inhibitory factor receptor and gp130 in mouse uterus during early pregnancy. Mol Reprod Dev 2002; 63: 143-150.
45. Nichols J, Davidson D, Taga T, Yoshida K, Chambers I, Smith A. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech Dev 1996; 57: 123-131.
46. Wang XN, Das SK, Damm. D, Klagsbrun M., Abraham JA, Dey SK. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen. Endocrinology 1994; 135: 1264-1271.
47. Sawai K, Matsuzaki N, Okada T, Shimoya K, Koyama M, Azuma C, et al. Human decidual cell biosynthesis of leukemia inhibitory factor: regulation by decidual cytokines and steroid hormones. Biol Reprod 1997; 56: 1274-1280.
48. Simon C, Mercader A, Frances A, Gimeno MJ, Polan ML, Remohi J, et al. Hormonal regulation of serum and endometrial IL-1 alpha, IL-1 beta and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supra-physiological steroid level conditions. J Reprod Immunol 1996; 31: 165-184.
49. Simon C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, et al. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994; 134: 521-528.
50. Braga VM, Gendler SJ. Modulation of Muc-1 mucin expression in the mouse uterus during the estrus cycle, early pregnancy and placentation. J Cell Sci 1993; 105 (Pt 2): 397-405.
51. Aplin JD, Meseguer M, Simon C, Ortiz ME, Croxatto H, Jones CJ. MUC1, glycans and the cell-surface barrier to embryo implantation. Biochem Soc Trans 2001; 29: 153-156.
52. Meseguer M, Aplin JD, Caballero-Campo P, O'Connor JE, Martin JC, Remohi J, et al. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst. Biol Reprod 2001; 64: 590-601.
53. Carson DD, Tang JP, Julian J. Heparan sulfate proteoglycan (periecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol 1993; 155: 97-106.
54. Smith SE, French MM, Julian J, Paria BC, Dey SK, Carson DD. Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation. Dev Biol 1997; 184: 38-47.
55. Kliman HJ, Feinberg RF, Haimowitz JE. Human trophoblast-endometrial interactions in an in vitro suspension culture system. Placenta 1990; 11: 349-367.
56. Wegmann T. The role of cytokine cross-talk in preventing abortion. Res Immunol 1990; 141: 185-188.
57. Garcia-LIoret MI, Morrish DW, Wegmann TG, Honore L, Turner AR, Guilbert LJ. Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp Cell Res 1994; 214: 46-54.
58. Gunawardana DH, Basser RL, Davis ID, Cebon J, Mitchell P, Underhill C, et al. A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancer. Clin Cancer Res 2003; 9: 2056-2065.
59. SERONO site. http://www.seronousa.com/news/archives/June3003.jsp. Accessed March 16, 2006.
60. Li TK, Fox BS. Effect of prostaglandin E2 (PGE2) on IL-3/ granulocyte-macrophage colony-stimulating factor production by T helper cells. Mode of stimulation and presence of costimulation can determine response to PGE2. J Immunol 1993; 150: 1680-1690.